Evaluation of penicillin-based inhibitors of the class A and B β-lactamases from Bacillus anthracis
- 16 January 2004
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 313 (3), 541-545
- https://doi.org/10.1016/j.bbrc.2003.11.158
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Biochemical Characterization of β-Lactamases Bla1 and Bla2 from Bacillus anthracisAntimicrobial Agents and Chemotherapy, 2003
- β-Lactamase Genes of the Penicillin-SusceptibleBacillus anthracisSterne StrainJournal of Bacteriology, 2003
- Clinical Role of ??-Lactam/??-Lactamase Inhibitor CombinationsDrugs, 2003
- Molecular analysis of beta-lactamase structure and functionInternational Journal of Medical Microbiology, 2002
- Problems associated with potential massive use of antimicrobial agents as prophylaxis or therapy of a bioterrorist attackClinical Microbiology & Infection, 2002
- Antibiotic Susceptibilities of 96 Isolates of Bacillus anthracis Isolated in France between 1994 and 2000Antimicrobial Agents and Chemotherapy, 2002
- In vitro resistance of Bacillus anthracis Sterne to doxycycline, macrolides and quinolonesInternational Journal of Antimicrobial Agents, 2001
- beta-lactamase epidemiology and the utility of established and novel beta-lactamase inhibitorsExpert Opinion on Investigational Drugs, 2000
- The synthesis and evaluation of 6-alkylidene-2'β-substituted penam sulfones as β-lactamase inhibitorsBioorganic & Medicinal Chemistry Letters, 1999
- β-Lactamases: protein evolution in real timeTrends in Microbiology, 1998